Oncotelic Therapeutics, Inc. (OTLC) Financials

OTLC Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 394.8 trillion 131.3 trillion
March 31, 2026 394.0 trillion 131.7 trillion
Dec. 31, 2025 393.1 trillion 131.4 trillion
Sept. 30, 2025 28.2 million 20.1 million

OTLC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -92200 2.4 trillion
March 31, 2026 -342243 1.6 million
Dec. 31, 2025 -783020 2.4 trillion
Sept. 30, 2025 -307027 183742

OTLC Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 -1.9 trillion
March 31, 2026 -2.2 million
Dec. 31, 2025 249.0 trillion
Sept. 30, 2025 -1.2 million

OTLC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 186.0 billion 1.9 million -
March 31, 2026 63.6 billion - -
Dec. 31, 2025 88.9 billion - -
Sept. 30, 2025 409000 - -

OTLC Shares Outstanding

No data available :(

OTLC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 3 345.0 million 1.1 trillion -
March 31, 2026 3 795.0 million 1.9 trillion -
Dec. 31, 2025 3 4.4 billion 3.2 trillion -
Sept. 30, 2025 5 426 490547 -

OTLC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 250000 -
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -

OTLC

Price: $0.02

52 week price:
0.02
0.11

Earnings Per Share: -0.01 USD

P/E Ratio: -4

Exchange: OQB

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 9.6 million

Links: